← Back to Clinical Trials
Recruiting NCT07333079

NCT07333079 Rehabilitation With Biofeedback for People After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07333079
Status Recruiting
Phase
Sponsor University of Rzeszow
Condition Rehabilitation
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2026-01-19
Primary Completion 2026-08-30

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Biofeedback method using the Biometrics E-link (group I) and Stella Bio (group II) devices.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2026-01-19 with a primary completion date of 2026-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the research will be to evaluate rehabilitation using the biofeedback method in people after stroke.

Eligibility Criteria

Inclusion Criteria: * informed, voluntary consent of the patient * age 45-80 years * elementary (basic) gripping ability * degree of paresis of the upper limb and hand 4 -5 on the Brunnström scale * degree of disability on the Rankin scale 3 * spastic tension of the upper limb, paresis hand not more than 3 on the modified Ashworth scale - current health condition confirmed by a medical examination, allowing participation in tests and exercises Exclusion Criteria: * lack of informed, voluntary consent of the patient * second or subsequent stroke, hemorrhagic stroke, stroke of the brainstem and cerebellum * disorders of higher mental functions limiting comprehension and carrying out tasks during exercises * visual field disturbances * mechanical and thermal injuries that may limit the grasping function of the hand * concomitant neurological, rheumatological and orthopedic diseases, including permanent - contractures that may affect the grasping ability and locomotion * unstable medical condition * failure to complete a 3-week rehabilitation stay

Contact & Investigator

Central Contact

Justyna Leszczak, PhD

✉ jleszczak@ur.edu.pl

📞 +48721581801

Principal Investigator

Justyna Leszczak, PhD

PRINCIPAL INVESTIGATOR

Univeristy of Rzeszów

Frequently Asked Questions

Who can join the NCT07333079 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07333079 currently recruiting?

Yes, NCT07333079 is actively recruiting participants. Contact the research team at jleszczak@ur.edu.pl for enrollment information.

Where is the NCT07333079 trial being conducted?

This trial is being conducted at Rzeszów, Poland.

Who is sponsoring the NCT07333079 clinical trial?

NCT07333079 is sponsored by University of Rzeszow. The principal investigator is Justyna Leszczak, PhD at Univeristy of Rzeszów. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology